**Relative Contraindications**

- Anthracycline hypersensitivity

- Patients with previous anaphylactic reactions following administration of anthracyclines

- Hepatic disease

- Patients with severe hepatic disease, defined as Child-Pugh class C or serum bilirubin greater than 5 mg/dL. Dosage adjustments are necessary for patients with mild to moderate hepaticÂ disease.

- Pre-existing cardiac conditions

- Heart failure, cardiomyopathy, myocardial infarction, myocarditis, pericarditis
- Assessment of cardiac function using a MUGA or echocardiogram is necessary before starting treatment in these patients.

- Gender

- Females have a higher risk of anthracycline-induced cardiotoxicity

- Age

- Children and adolescents have a higher risk of developing late cardiovascular dysfunction. They should receive periodic cardiac evaluations.

- Reports of prepubertal growth inhibition/failure and gonadal impairment in children and adolescents

- Pregnancy (category D)

- In animal studies

- Breastfeeding

- Live vaccines